Cystic Fibrosis clinical trials in Washington
18 active Cystic Fibrosis trials with a site in Washington. Describe your situation to see which ones you may be eligible for.
- Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
- Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
- 4D-710 in Adult Patients With Cystic Fibrosis
- A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
- IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
- Ensuring Access to Optimal Therapy in CF: The ENACT Study
- Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Remote Sputum Collection in Cystic Fibrosis
- Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
- A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
- Health Outcomes of Parents With Cystic Fibrosis-Aim 2
- Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
- Lung Transplant READY CF 2: CARING CF Ancillary RCT
- Rethinking Early Airway Clearence Therapies
- Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria
- Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
- Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.